ArticleScience (New York, N.Y.)2017
Integrated view of
Open access · bronzeAbstract read
In one paragraph
Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.
0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
15.3field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
94 citing papers in PubMed, 176 citations in OpenAlex.
- Pangenome ofEcology and evolution · 2026Article
- Evolution of pandemic cholera at its global source.Nature · 2026Article
- Pandemic Vibrio cholerae and the Environmental Reservoir Hypothesis-Outstanding Questions Central to Global Cholera Control.Environmental microbiology · 2026Article
- Wave succession in the pandemic clone of Vibrio parahaemolyticus driven by gene loss.Nature ecology & evolution · 2026Article
- Public health surveillance ofJournal of medical microbiology · 2026Article
- CholeraSeq: a comprehensive genomic pipeline for cholera surveillance and near real-time outbreak investigation.Bioinformatics (Oxford, England) · 2026Article
- Genome-wide investigation of outbreak-associatedFrontiers in microbiology · 2026Article
- Population structure and phylogenetic analysis of Vibrio cholerae non-O1/O139 by whole genome sequencing.PloS one · 2026Article
- Genomic diversity and antimicrobial resistance ofMicrobial genomics · 2025Article
- Defence systems encoded by core genomic islands of seventh pandemicPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025Review
- Lineage-specific defence systems of pandemicPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025Review
- Vibrio cholerae endemic to the lower Rio Grande Delta segregate into urban and rural phylotypes.Scientific reports · 2025Article
- Spatio-temporal pattern and risk factors associated with cholera outbreaks in selected high-risk areas of Kenya.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025Article
- Allelic variations and gene cluster modularity act as nonlinear bottlenecks for cholera emergence.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- West African-South American pandemic Vibrio cholerae encodes multiple distinct phage defence systems.Nature microbiology · 2025Article
- Non-O1/O139 environmental Vibrio cholerae from Northern Cameroon reveals potential intra-/inter-continental transmissions.PLoS neglected tropical diseases · 2025Article
- Application of Comparative Genomics for the Development of PCR Primers for the Detection of Harmful or Beneficial Microorganisms in Food: Mini-Review.Foods (Basel, Switzerland) · 2025Review
- Non-toxigenicArchive of clinical cases · 2025Review
- Genomic evidence of two-staged transmission of the early seventh cholera pandemic.Nature communications · 2024Article
- Surveillance of travel-associated isolates elucidates the diversity of non-pandemicMicrobial genomics · 2024Article
34 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
20 authors at 9 institutions in 6 countries.
Daryl DommanWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK. dd6@sanger.ac.uk nrt@sanger.ac.uk.ORCID 0000-0001-5389-9185
Marie-Laure QuiliciInstitut Pasteur, Unité des Bactéries Pathogènes Entériques, Paris, 75015, France.
Matthew J DormanWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.ORCID 0000-0001-7064-6163
Elisabeth NjamkepoInstitut Pasteur, Unité des Bactéries Pathogènes Entériques, Paris, 75015, France.ORCID 0000-0001-6791-6003
Ankur MutrejaWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Alison E MatherWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Gabriella DelgadoDepartment of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico, D.F., Mexico.ORCID 0000-0003-4577-4440
Rosario Morales-EspinosaDepartment of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico, D.F., Mexico.ORCID 0000-0003-2110-4397
Patrick A D GrimontInstitut Pasteur, Unité Biodiversité des Bactéries Pathogènes Emergentes, Paris, 75015, France.ORCID 0000-0002-6264-136X
Marcial Leonardo Lizárraga-PartidaCentro de Investigación Científica y de Educación Superior de Ensenada, Baja California, (CICESE), Ensenada, Baja California, Mexico.ORCID 0000-0001-9675-3813
Christiane BouchierInstitut Pasteur, Plate-forme Génomique (PF1), Paris, 75015, France.ORCID 0000-0003-3549-1543
David M AanensenCentre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Pablo Kuri-MoralesSubsecretaría de Prevención y Promoción de la Salud, Secretaría de Salud, Ciudad de México, Mexico.ORCID 0000-0002-0704-9507
Cheryl L TarrEnteric Diseases Laboratory Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-6290-365X
Gordon DouganWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.ORCID 0000-0003-0022-965X
Julian ParkhillWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.ORCID 0000-0002-7069-5958
Josefina CamposInstituto Nacional de Enfermedades Infecciosas, ANLIS, Buenos Aires, Argentina.ORCID 0000-0003-1409-0441
Alejandro CraviotoFaculty of Medicine, Universidad Nacional Autónoma de México, Mexico, D.F., Mexico.ORCID 0000-0001-7357-0010
François-Xavier WeillWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.ORCID 0000-0001-9941-5799
Nicholas R ThomsonWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK. dd6@sanger.ac.uk nrt@sanger.ac.uk.ORCID 0000-0002-4432-8505
Institut Pasteur · FRUniversidad Nacional Autónoma de México · MXUniversity of Cambridge · GBWellcome Sanger Institute · GBAdministración Nacional de Laboratorios e Institutos de Salud · ARCenters for Disease Control and Prevention · USCentro de Investigación Científica y de Educación Superior de Ensenada · MXSecretaria de Salud · MXUniversity of London · GB
Funding
Wellcome Trust 098051
Abstract
Latin America has experienced two of the largest cholera epidemics in modern history; one in 1991 and the other in 2010. However, confusion still surrounds the relationships between globally circulating pandemic
Indexed as
CholeraCommunicable Disease ControlDrug Resistance, Multiple, BacterialHumansLatin AmericaPandemicsSequence Analysis, DNAVibrio cholerae
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.